News
HDV was discovered in patients infected with hepatitis B virus (HBV). It generally makes HBV infections more damaging to the liver. It is a subviral satellite agent that depends upon HBV envelope ...
Immunocore reports first quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $93.9 million in Q1 2025, growing by 33% year-over-year ...
There's a vaccine for hepatitis B that, according to the CDC, can help to prevent millions of deaths worldwide.
Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical outcomes of ...
Dynavax is kicking off May’s Hepatitis Awareness Month with a new push to improve education around hepatitis B and the ...
The hepatitis delta virus (HDV) is transmitted primarily through contact with infected blood, similar to hepatitis B virus (HBV). People who inject drugs face a high risk, partly because of needle ...
A pioneering study uncovers crucial immune dynamics in hepatitis B, offering new insights into how immune responses evolve ...
An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...
Functional cure of chronic hepatitis B (CHB) remains a major clinical challenge. Current therapies—including nucleos(t)ide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results